Sep 21, 2017 - Correction: Coenzyme Q10 plus Multivitamin. Treatment Prevents Cisplatin Ototoxicity in. Rats. Laura Astolfi, Edi Simoni, Filippo Valente, Sara ...
CORRECTION
Correction: Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats Laura Astolfi, Edi Simoni, Filippo Valente, Sara Ghiselli, Stavros Hatzopoulos, Milvia Chicca, Alessandro Martini
a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
In the Introduction, the sentence "The Q-TER1 is obtained by terclatration, a patented solidstate physical procedure (WO/2003/097012, Actimex Srl, Piacenza, Italy) in which the coenzyme (10% w/w) is added to a carrier and a catalyst [34]," the word “Piacenza” should be replaced with "Trieste." In the Drugs sub-section of the Materials and Methods section, the first sentence should read: The Q-TER1 was provided by Scharper S.p.A. (Milan, Italy). Acuval 4001, a dietary multivitamin supplement containing vitamins A, E, B1, B2, B6 and B12, L-Arginine, Ginkgo biloba extract, minerals (Mg, Se, Zn) and a small amount of Q-TER1 (0.31 g/100 g), was provided by Scharper S.p.A. (Milan, Italy). There is an error in the Funding section. The correct funding information is as follows: The work was supported by the Scharper S.p.A. (Milan, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There is an error in the Competing Interests section. The correct Competing Interests statement is: The work was supported by the Scharper S.p.A. (Milan, Italy). This does not alter our adherence to PLOS ONE policies on sharing data and materials. There is an error in the Acknowledgements section. This section should read: We are grateful to Dr. G. Manini and Dr. D. Bellini for providing us the ACUVAL4001 and the Q-TER1 (Scharper, S.p.A.). The authors owe thanks also to Dr V. Cascella and Dr. P. Giordano for helpful discussion on the first draft of the manuscript.
Reference 1. OPEN ACCESS
Astolfi L, Simoni E, Valente F, Ghiselli S, Hatzopoulos S, Chicca M, et al. (2016) Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats. PLoS ONE 11(9): e0162106. https://doi. org/10.1371/journal.pone.0162106 PMID: 27632426
Citation: Astolfi L, Simoni E, Valente F, Ghiselli S, Hatzopoulos S, Chicca M, et al. (2017) Correction: Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats. PLoS ONE 12(9): e0185525. https://doi.org/10.1371/journal. pone.0185525 Published: September 21, 2017 Copyright: © 2017 Astolfi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PLOS ONE | https://doi.org/10.1371/journal.pone.0185525 September 21, 2017
1/1
